TF and plasma cell myeloma: To identify other TF potentially regulating CCND2 enhancer activity in CCND2-expressing HD MM (which lack expression of MAF), we performed differential footprinting analysis in CCND2high vs CCND2low HD myeloma PC (Fig. 5g and Supplementary Fig. 6f and g).